ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange


08/11/2019

New issue announcement, application for quotation of additional securities and agreement 

06/11/2019

Cellmid signs trading agreement with API-Priceline

06/11/2019

Cellmid Share purchase plan completed

31/10/2019

Cellmid appoints CEO to Advangen USA to expand distribution

24/10/2019 

Supplementary Information on Annual general meeting resolutions

23/10/2019

Cellmid notes to the Appendix 4C

16/10/2019

Cellmid Limited Notice of 2019 Annual General Meeting

16/10/2019

Appendix 3B New issue announcement, application for quotation of additional securities and  agreement

15/10/2019

Share Purchase Plan Offer Booklet

15/10/2019

Cleansing notice under ASIC corporations (Share and interest purchase plans) instrument  2019- 547

14/10/2019

Cellmid signs new TV shopping agreement for Evolis

14/10/2019

Cellmid share placement raises $1.5 million

10/10/2019

Market Announcement - Cellmid Limited ASX-CDY - Trading Halt

01/10/2019

Cellmid signs new distribution agreement for Evolis and Opens in Europe with leading retailer

27/09/2019

Cellmid receives $840K R&D Tax Credit

16/09/2019

Appendix 4G and Corporate Governance Statement

16/09/2019

2019 Annual Report to shareholders

28/08/2019  

FY19 Results Presentation 

28/08/2019

Appendix 4E and FY19 Financial Report

28/08/2019  

FY2019 Financial Results

22/08/2019

Patent for Improved Midkine Antibody Allowed in Europe

06/08/2019

Cellmid signs distribution agreement for Evolis in South Korea

01/08/2019

Appendix 4C Query

31/07/2019

Appendix 3B New issue annoucement, application for quotation of additional securities and  agreement

26/07/2019

Cellmid Notes to the Appendix 4C

10/07/2019

Cellmid Investor Newsletter

05/07/2019

ASX Aware Query

04/07/2019

Cellmid sets another sales record in Q4 FY2019

06/06/2019

Change of Director's Interest Notice 

28/05/2019

Cellmid appoints Lyramid CEO to Accelerate Partnering

28/05/2019

FY2020 Growth Strategy Update May 2019

23/05/2019

Minimum holding buy-back completed

21/05/2019

Minimum holding buy-back closed

06/05/2019

Appendix 3Y - Change of Director's Interest Notice

30/04/2019

Cellmid's evolis registered in European Union

29/04/2019

Cellmid notes to the Appendix 4C

18/04/2019

Repayment of Cellmid loan issued to Director pursuant to employee incentive plan

02/04/2019

Cellmid Alopecia Patent allowed in Europe

26/03/2019

Cellmid Investor Newsletter March 2019

19/03/2019

Minimum Holding Share Buy-Back

21/02/2019

Appendix 4D, Half Year Accounts and Strategy Update

07/02/2019

Significant New Findings Published On MIDKINE

23/01/2019

Appendix 4C and Notes to Appendix 4C